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Imaging Sciences Retreat
Pathways to Discovery
In the future, solving complex biomedical problems may be determined
by how well the next generation of imaging scientists is trained in basic
biological issues and technical know-how. Washington University's innovative
curriculum—called Imaging Sciences Pathway (ISPj—offers a unique learning
experience for undergraduate and graduate students from several disciplines.
In April 2008, the Imaging Sciences Retreat
highlighted the ISP as well as the students who _
are enrolled in this challenging program.
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Top, left: Keynote Speaker Robert Balaban, PhD,

Top, right: Kari Alca coordinated the registration for

of the National Heart Lung and Blood Institute's

the Retreat, which was held at the Hyatt Regency

Laboratory of Cardiac Energetics, spoke on

St. Louis Riverfront.

"In vivo sub-cellular imaging using non-linear
optical microscopy."

Right: Carolyn Anderson, PhD, professor of radiology
and codirector of ISP, presented an update of the
Imaging Sciences Pathway initiative.

Photography by Mickey Wynn, MIR Photography lab
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After five years in the making, the
CCIR—a comprehensive imaging
center dedicated to innovative
research—hosted an open house in
February of this year.
8 Radiotherapy for Graves' Disease

A nuclear medicine specialist discusses the safety and effectiveness
of using radiotherapy to manage
Graves' disease, the most common
cause of hyperthyroidism.
13 Resolving the Mysteries of Autism

A five-year national study involving
siblings of children diagnosed with
autism uses magnetic resonance
imaging to investigate structural
and functional neural development.

1 8 The National Oncologic
PET Registry

The results of a nationwide effort
to measure the effect that findings
of PET scans have on cancer treatment decisions may lead to changes
in the Center for Medicare and
Medicaid Services coverage policy.
■ On Duty in Iraq

A Mallinckrodt Institute physician
shares his experiences as the only
radiologist on duty at the 325th
Combat Support Hospital, the primary United States military healthcare facility in Al Anbar province.
ON THE COVER Magnetic resonance imaging-based
research involving volunteers like this little girl may

Visit the MIR web site at
www.mir.wustl.edu

provide new insights into diagnosing autism in very
young children.

Courtesy photo.
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►TNEWS
SCC earns excellence award
WUSM moves up a notch
In the 2008 U.S. News & World Report rankings,
Washington University in St. Louis School of Medicine
(WUSM) moved from its 2007 fourth-place spot and is
now positioned third in overall rankings among
research-oriented medical schools. WUSM continues
to hold first place in student selectivity, based on
college grade-point averages and MCAT scores. Other
medical schools listed in the top five are Harvard
University (ranked first); Johns Hopkins University
(second); University of Pennsylvania (fourth); and
University of California, San Francisco (fifth).

The American College of Radiology (ACR) has
designated the Joanne Knight Breast Health Center at
Siteman Cancer Center (SCC) as a Breast Imaging Center
of Excellence. The Center of Excellence award recognizes the SCC for earning accreditation in all of the
ACR's voluntary breast-imaging accreditation programs
and modules as well as the mandatory Mammography
Accreditation Program. The SCC's breast imaging
services are fully accredited in mammography,
stereotactic breast biopsy, breast ultrasound, and
ultrasound-guided breast biopsy.

Middleton named Teacher
of the Year
Radiology senior residents annually present the
Diagnostic Radiology Teacher of the Year award to a
faculty member who has made outstanding contributions
to resident education. William Middleton, MD, professor
of radiology—and the 2007-2008 honoree—is a twotime recipient.
PAST RECIPIENTS

David Ling, MD
Fernando Gutierrez, MD
Dennis Balfe, MD
Stuart Sagel, MD
Marilyn Siegel, MD
Barry Siegel, MD
Franz Wippold, MD
Anthony Wilson, MD
William Middleton, MD
Jay Heiken, MD
Gary Shackelford, MD
Mokhtar Gado, MD
Premsri Barton, MD
Harvey Glazer, MD
William Totty, MD
Thomas Herman, MD
Barbara Monsees, MD
William McAlister, MD
Sanjeev Bhalla, MD
Christine Menias, MD
Katie Vo, MD
Vamsi Narra, MD
Robert McKinstry, MD, PhD

1985
1986
1983 and 1987
1988
1984 and 1989
1990
1991
1992
1993
1994
1995
1996
1997
1998
1999
2000
2001
2002
2003
2004
2005
2006
2007

Middleton is shown with Sara Rohr, MD, 2007-2008 diagnostic
radiology chief resident.

MALLINCKRODTINSTITUTE OFRADIOLOGl

Matching Program results
announced
In July, 18 physicians will begin their first year of
training in diagnostic radiology at Mallinckrodt
Institute. The 2008-2009 trainees come from the
following schools:
• Albert Einstein College of Medicine,
Yeshiva University (1)
• Duke University School of Medicine (2)
• Kazan State Medical University (1)
• Mount Sinai School of Medicine of New York
University (1)
• New York Medical College (1)
• Pontificia Universidad Catolica de Chile (1)
• Pritzker School of Medicine, University of Chicago (1)
• Saint Louis University School of Medicine (1)
• Southern Illinois University School of Medicine (1)
• University of California Los Angeles David Geffen
School of Medicine (1)
• University of Louisville School of Medicine (1)
• University of Miami School of Medicine (1)
• University of Texas Medical School at Houston (2)
• Washington University in St. Louis School of
Medicine (3)

I Wilson Award in its 40th year
The 2008 Hugh M. Wilson Award for Meritorious
Work in Radiology was presented on May 16, at the
senior program following Washington University's 147th
Commencement ceremony, to two outstanding recipients:
Michael Fox, and Mai-Lan Ho. Fox, an MD/PhD student,
completed his doctoral research in the Neuroimaging
Lab with Marcus Raichle, MD, professor of radiology, of
neurology, of neurobiology, and of psychology. Ho, a
fourth-year medical student, worked in the Abdominal
Radiology section under the mentorship of Vamsi Narra,
MD, associate professor of radiology. The annual Wilson
Award honors Mallinckrodt Institute's second director,
an advocate of the advancement of education.
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Gilbert Jost, MD, head of the Department of Radiology and director of Mallinckrodt
Institute, was one of three physicians named as honorary members of the European Society of Radiology ot the Society's annual meeting in Vienna. Honorees:
(left to right) Jost; Lizbetfi Kenny, MD, director of Cancer Services for the Central
Area Health Service, Royal Brisbane (Australia) and Women's Hospital; and
Frederick Keller, MD, chair of the Department of Radiology and director of the
Dotter Interventional Institute of the Oregon Health and Science University.

Haven joins the
Institute
Joy Haven, PhD, newly
appointed executive officer for
business operations, comes to
Mallinckrodt Institute from the
Washington University School of
Medicine (WUSM) Cardiovascular
Division, where she served as
executive officer for six years.
Prior to her WUSM experience,
she held leadership positions in the
medical insurance field. Haven
graduated summa cum laude from
Washington University with a double major in economics and psychology. She also
earned an MBA and a doctoral degree in clinical
psychology at the University.
Haven's appointment was announced as Linda
Davidson, executive director of business affairs and an
MIR employee for 21 years, transitions to retirement.

►TNEWS
Of note

Benzinger receives dual awards

The Washington
University School of Medicine (WUSM) Alumni
Association Executive
Committee named one
of the four WUSM Distinguished Professor 2008
scholarships in honor
of Emily Smith, MD,
assistant professor of
radiology. The four-year,
full-tuition, merit-based
scholarships are awarded
annually to first-year
medical students.
Vamsi Narra, MD,
associate professor of
radiology, was named
chief of radiology at
Barnes-Jewish West
County Hospital. Narra
also is chief of clinical
operations at the West
County Hospital, where
enhanced radiology services are an integral part
of Washington University
School of Medicine's
expanded operations.

Tammie Benzinger, MD, PhD,
assistant professor of radiology,
may be the only honoree to have
been named an ARRS Scholar and
an ASNR/NER Foundation Scholar
in the same year. Benzinger, a
neuroradiologist, received both awards
based on her research involving
magnetic resonance imaging (MRI).
The two-year American Roentgen Ray Society (ARRS) /Bracco
Diagnostics award of $140,000 will
fund the use of MRI to better
understand the microstructural
environment of the central nervous
system—a collaborative study
between Mallinckrodt Institute's
Center for Clinical Imaging
\
Research (CCIR) and the Beckman
Institute at the University of Illinois at Urbana-Champaign (UIUC). Benzinger's mentors
for this project are Victor Song, PhD, associate professor of radiology; Mark Mintun,
MD, professor of radiology and of psychiatry, and director of the CCIR; and Zhi-Pei
Liang, PhD, at UIUC. The focus of the $60,000 American Society for Neuroradiology
(ASNR)/National Education and Research (NER) Foundation scholarship is the application of MRI directional diffusivity as a tool for prognosis and response to therapy in
childhood leukodystrophy with neuromuscular disability.

Becky Salmo, manager, information systems, was a member of a delegation of
healthcare information and management system professionals that travelled to
India, an emerging leader in the field of health information technology. During
the eight-day visit, the delegation—sponsored by People to People Citizen
Ambassador Programs and in partnership with the Healthcare Information
and Management Systems Society (HIMSS)—met with representatives
of various healthcare groups, including New Delhi's Maulana Azad Medical
College (one of India's premier medical schools) and its five associated
hospitals, and Indraprastha Apollo, the largest hospital in the Apollo Hospitals
Group, the largest integrated healthcare company in India; and Fortis
Healthcare Ltd, the leading healthcare provider in North India. Salmo (left)
is shown receiving a plaque from a representative of Fortis Healthcare Ltd,
citing the HIMSS visit to create global synergies in the development of
healthcare technology.
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Mark Mintun, MD, professor of radiology and director of Mailinckrodt Institute's Center for Clinical Imaging Research (CCIR), is understandably proud of
this multimillion-dollar facility that provides an enormous opportunity for advancing
medical science and improving clinical care. From the first planning discussions in
2003 to the installation of the most advanced, FDA-improved imaging technology in
2007, the CCIR has been eagerly anticipated by the Washington University School
of Medicine (WUSM) research community. With the February 28th Open
House, the facility was officially presented to Mailinckrodt Institute faculty and staff,
WUSM clinicians and researchers, and industry collaborators.
Photography by Kimberly Kania, MIR Photography Lab

The Center for
Clinical Imaging
Research

(Left to right) Doctors Lorry Shapiro, executive
chancellor (or medical affairs and dean of the
School of Medicine; Gilbert Jost, head of the
Department of Radiology and director of
Mallinckrodt Institute; Mark Mintun; and Mark
Wrighton, chancellor of Washington University, presided at the ribbon-cutting ceremony
that officially opened the CCIR.
r%

Above: Scott Love, RT, MRI technol-

| lie Center t

ogist, discusses magnetic resonance
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imaging with Washington University
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Chancellor Mark Wrighton.
Left: Magnetic resonance imaging
scanner (MRI), one of two
high-powered units in the CCIR
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Right: (Second from left) John Kotyk, PhD,
CCIR associate director, led a tour of the
positron emission tomography/computed
tomography (PET/CT) area.
Below: CT Supervisor Tim Street (third
from right) answers questions about the
64-slice CT scanner.

The CCIR staff: (left to right) Betsy Thomas, RN,
CCRC, clinical research specialist and protocol
developer; Mark Nolte, RT, MRI technologist; Linda
Becker, CNMT, PET technologist; Michael Harrod,
CNMT, PET technologist; Marion Harris, division
administrator; Tim Street, RT(R)(CT), CT supervisor;
Scott Love, RT, MRI technologist; Crystal CannonHenderson, medical secretary; and Dott Wallace,
special project administrator. Not shown are Robin
Link, administrative coordinator; Ruth Hofdener, RT,
research patient coordinator; Glenn Foster, RT, MRI
supervisor; Christopher Allen, RT, ultrasound
technologist; Matthew House, systems manager;
Steve Baldwin, senior programmer analyst; and
Weimin Shen, senior programmer analyst.
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RADIOTHERAPY

FOR

GRAVES' DISEASE
DISPELLING THE MYTHS
by Amy Thomas

From the classic,

Major Endocrine Glands
Male

Female

"What your doctor
won't tell you," to the
pointed, "Top 20 reasons

Pineal gland

Pituitary gland

why I'll never have radioiodine
therapy," Internet posts by the
lay public often enhance com-

Thyroid gland

mon suspicions about the use
of radioactive agents (or radio-

Thymus

pharmaceuticals) in the treatment of Graves' disease
(GD)—the most common
cause of hyperthyroidism that

Adrenal gland
Pancreas

affects women up to 10 times
more often than men.
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Testis
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Patients with GD often

Ovary

experience a period of vague
complaints such as fatigue
or weight loss before a
diagnosis is evident.

The initial abatement of anxiety
upon learning the cause of
their ailments is short-lived
and followed by uncertainty
regarding treatment options—
particularly the use of radioactive
iodine. Anxiety-provoking statements
can burden the informed consent
of patients with GD and cause
undue stress for both former and
potential recipients of radioactive
iodine therapy. But based on experience and clinical studies, nuclear
medicine specialists like Bennett
Greenspan, MD, instructor in radiology at Mallinckrodt Institute,
agree that radiotherapy is a safe
and effective management choice.

to make a definitive diagnosis. The
subtle evolution of symptoms may
cause a patient to disregard the
early warning signs or to attribute
symptoms to stress and aging.
More specific symptoms—like
tachycardia (rapid heart rate),
tremor (in the hands, for example),
and brittle hair—alert the clinician
to possible thyrotoxicosis. Classic
signs of skin disease (especially
thickening of the skin) and eye
disease (most notably, the protuberance of one or both eyes) can
firmly establish the diagnosis of
GD. Untreated, GD can result in
serious complications, including
cardiac rhythm disturbance and
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Hyperthyroidism in GD is due to an autoimmune
process in which thyroid-stimulating antibodies
bind receptors on the thyroid gland, resulting
in an increased production of thyroid hormones
T3 and T4.
A closer look at the role of radioactive
iodine in the evaluation and treatment
of Graves' disease provides much
needed reassurance for patients.
THE THYROID AND ITS HORMONES

The thyroid gland, a butterflyshaped organ situated in the neck
near the larynx and the trachea, is
one of the largest endocrine glands
in the human body. It produces
hormones (T3 and T4, of which
iodine is an essential component)
that control metabolism, protein
production, and sensitivity to
other hormones.
Because thyrotoxicosis (excessive levels of thyroid hormone)
affects many organ systems, the
early manifestations of GD—
including anxiety, insomnia,
irritability, and weight loss—are
not specific enough for physicians

FOCAL SPOT, SPRING 2008

vision loss. The course of disease
without treatment is thyroid
burnout and reduced function over
an extended time.
Hyperthyroidism in GD is due
to an autoimmune process in which
thyroid-stimulating antibodies bind
receptors on the thyroid gland,
resulting in an increased production
of thyroid hormones T3 and T4.
The clinical presentation is due to
the various effects of excess thyroid
hormone, in addition to autoimmune-mediated inflammation of
ocular and connective tissue.
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Top: Normal thyroid scan
Middle: Graves' disease: diffuse, uniform enlargement
of thyroid gland
Bottom: Multinodular goiter: enlarged thyroid gland
but irregular in uptake; nodules vary in size and levels
of function. Can cause symptoms of hyperthyroidism.
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FOR

GRAVES' DISEASE
DISPELLING THE MYTHS

DIAGNOSTIC IMAGING

Patients with thyrotoxicosis
may initially be evaluated by
ultrasound, which can detect nodules
a doctor cannot feel during a
patient's physical examination and
can identify an enlarged thyroid
gland with increased blood flow
that is consistent with a diagnosis
of Graves' disease. But ultrasound
cannot show thyroid function.
Nuclear imaging of the thyroid
allows visualization of biologic
processes at the cellular level and
provides useful information about
thyroid activity. Patients are often
referred to a nuclear medicine
physician for diagnosis confirmation
and for subsequent treatment of
GD with radiotherapy.
Radioactive iodine uptake and
thyroid scanning are the diagnostic
studies most often used to determine
Graves' disease; the isotope 1-123 is
typically the agent of choice. In a

thyroid uptake test, 1-123 taken
orally is concentrated in the thyroid
gland. A gamma camera, which
detects and localizes emitted radiation, is used to calculate the thyroid's
iodine uptake. Increased iodine
uptake indicates increased de novo
synthesis (in which simple molecules
turn into complex molecules
instead of being recycled) of thyroid
hormone, which is consistent with
a hyperactive gland. Normal values
for 24-hour radioiodine uptake are
between 10 percent and 30 percent,
while uptake in patients with GD is
typically in the range of 50 percent
to 80 percent.
Uptake tests are usually done
over a two-day period, with imaging
performed when radiotracer uptake
is maximal (24 hours for 1-123), and
there are precautions for patients:
• Discontinue use of thyroid medications prior to the examination
as these agents could reduce iodine

Normal values for 24-hour radioiodine uptake are
between 10 percent and 30 percent, while uptake!
in patients with GD is typically in the range of 50'
percent to 80 percent.
Top: Solitary hypofunctioning nodule: one nodule,
functioning less than normal thyroid tissue. Not relevant to Graves' disease.
Middle: Autonomous nodule: can function to greater
degree than remainder of thyroid gland. Acts as
feedback mechanism to keep thyroid functioning
normally. Commonly suppresses remainder of thyroid.
May cause symptoms of hyperthyroidism similar to
Graves' disease. Can be distinguished from Graves'
disease by thyroid scan.
Bottom: Subacute thyroiditis: produces symptoms of
hyperthyroidism by causing injury to gland from
inflammatory process. Thyroid "leaks" hormone,
producing symptoms identical to Graves' disease.
Distinguished from Graves' disease by thyroid

uptake to the normal range despite
the presence of Graves' disease.
• Do not undergo computed tomography (CT) screening for four to
six weeks prior to a scheduled
uptake test because the iodinated
contrast agents used with CT)
may interfere with the uptake test.
• Do not use amiodarone, an iodinerich medication, ideally for three
to six months prior.
• Avoid other agents, including
cough syrups, some vitamin
preparations, and seaweed (kelp).

uptake and thyroid scan.

10
MALLINCKRODT INSTITUTE OF RADIOLOGY

Since radioiodine uptake can
the neck—is also a common finding.
Following 1-131 therapy,
confirm a diagnosis of GD and furNo specific safety precautions are
patients must have follow-up
ther imaging is unlikely to change
needed with the use of 1-123: It is
laboratory studies throughout their
the management of the disease,
administered at a low dose and
lifetime. Most patients will develop
thyroid scanning is performed less
does not emit beta rays, so radiation
hypothyroidism but, since hormone
often; however, it may be useful in
exposure is negligible compared to
replacement therapy is effective
differentiating Plummer's disease
that of other radioisotopes.
and inexpensive, many consider
from that of GD superimposed on
a nodular goiter. Though both
fc^The added benefits are a shortened duration of
conditions can be treated with
radioactive iodine, the dose needed
symptoms and less risk of complications from
to treat GD is usually lower. Thyroid
scans of patients with GD typically
sustained antithyroid medication use...??
reveal a gland with smooth contours and diffusely increased
A SAFE AND EFFECTIVE CHOICE
hypothyroidism a more manageable
radioiodine uptake. A prominent
Treatment with radioiodine
condition and view it as a goal of
thyroid pyramidal lobe—one of the
(1-131) is the most commonly used
treatment rather than an adverse
thyroid's four components and
therapy for GD in the United
effect. Progression of eye disease
descending from the base of the
States, with efficacy at more than
is a serious consideration for
tongue into the anterior midline of
90 percent. Contrary to popular
patients with severe Graves'
belief, studies of adults with GD
ophthalmopathy who are undergoing
who are treated with 1-131
radioiodine therapy, but recent
show no subsequent risk of
studies suggest that low-dose steroids
any kind of cancer, including
may lower this risk. Another conthyroid cancer or lymphoma.
cern for elderly patients and those
Treatment begins to take
with underlying cardiac disease
effect in two to three weeks,
or severe thyrotoxicosis is the
maximal results occur
temporary worsening of symptoms
between three and four months,
as radioiodine destroys the gland.
and the end result includes
Doctors often pre-treat this group
many patients who are
with antithyroid medications to
thankful for the resolution of
minimize the risk.
their symptoms. While antithy"We are just speeding up the
roid medications such as
natural process of GD," says
propylthiouracil (PTU) and
Greenspan. "The added benefits
methimazole (MMI) are reaare a shortened duration of symptoms
sonable alternatives, they have
and less risk of complications from
a 50 percent failure rate and
sustained antithyroid medication
can cause rare but severe
use. All we have done is to acceleradverse effects, including
ate the process already underway
suppression of white blood
but, in doing so, we have cured
cells (agranulocytosis), liver
the disease."
toxicity, and vasculitis (blood
vessel inflammation). Given
these risks, clinicians and
patients often opt to go
directly to radioiodine therapy,
a safe and effective choice.

Bennett Greenspan, MD, is a past president of the
American College of Nuclear Physicians and of the
Missouri Radiological Society.
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PROPER PRECAUTIONS

Greenspan emphasizes that
an uptake test must always be
obtained before treatment begins.
Occasionally patients will have
uptakes in the normal range and,
although subacute disease may be
present, they should not be treated
for two reasons: the possibility
of another diagnosis; and, with
normal uptake, the need for three

Most important in determining
dosage, says Greenspan, is not to
lose sight of the goal of radiotherapy:
"While saying that thyroid activity
should be reduced to a normal
level is plausible, in reality it is very
hard to do. It is prudent to slightly
overestimate the amount of
radioiodine needed rather than
try to give the exact dose, fall
short, and then retreat."

^V..While saying that thyroid activity should be
reduced to a normal level is plausible, in reality it is
very hard to do... 99
to five times the usual dose of
radioiodine to achieve therapeutic
concentrations in the thyroid gland.
While some medical facilities
use a fixed-dose method, Mallinckrodt
Institute radiologists calculate the
radioiodine dose to allow the highest likelihood of treatment success
using the least amount of 1-131.
Patients with high uptake ranges
can be effectively treated with
lower doses of radioiodine, as
more of the isotope reaches the
gland. In contrast, patients with
larger thyroids need a higher dose
of radioiodine to effectively reduce
the gland's function.

FOR MORE INFORMATION
National Graves' Disease
Foundation: www.ngdf.org
American Thyroid Association:
www.thyroid.org
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As with 1-123 studies, there are
some precautions:
• Discontinue use of antithyroid
medications and iodine-rich
agents prior to radiotherapy.
• Do not administer 1-131 to pregnant patients due to the risk of
fetal thyroid damage and death.
• Avoid pregnancy for one year
after treatment.
• Have a negative pregnancy test,
ideally the day of or day prior to
treatment, required for women of
child-bearing age.
• Nursing mothers must stop
breastfeeding their infants three
to four weeks before treatment
and cannot resume post-therapy.
MAXIMIZING SAFETY OF OTHERS

The practice mandate called
ALAEA—"As Low As Reasonably
Achievable"— indicates minimizing
radiation exposure to only that
needed for diagnosis or treatment.
Although any theoretical risk is
small, anyone exposed to a treated
patient before the radioiodine is
cleared from the body incurs risk
without benefit—an undesirable
risk-benefit ratio. Exposure is
minimized with a few simple measures: time, distance, and hygiene.

• Exposure in one minute is one
tenth of the amount of exposure
in 10 minutes, and a distance
twice as far from the radiation
source results in one quarter of
the exposure.
• Sitting across the room from a
treated patient for a few minutes
is significantly less exposure than
sitting on that person's lap for the
same few minutes.
• If the car ride home is more than
two hours, the patient may want
to sit in the back seat, opposite
the driver's side.
• Because radioiodine is excreted
in urine, feces, and perspiration,
good hygiene can also reduce
unnecessary exposure to others,
including laundering clothing,
bed linens, towels, and utensils
separately from those of other
family members; showering daily;
washing hands frequently; and
flushing the toilet two to three
times after voiding.
• Physicians also recommend that
patients abstain from having sexual intercourse for three to four
days after treatment.
• Patients should avoid contact
with pregnant women and young
children, especially infants, for
at least one week.
Radioactive iodine fills a gap in
treating GD by providing an option
other than surgery or medications
with high failure rates. Greenspan
concludes, "Quite frankly, radioactive iodine is a very effective and
safe treatment for Graves' disease.
I would choose this option for
myself and my family members if
the need arose. If done with proper
precautions and appropriate dose
calculation, it works." EH3
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RESOLVING THE MYSTERIES OF

In Mallinckrodt Institute of Radiology's
East Building, what was a technologically sophisticated
but otherwise plain magnetic resonance imaging
(MRI) suite has been converted into a cozy nursery with
rocking chairs, a crib, and blankets. Customized to
accommodate an uncommon group of study
participants, it's the site of seminal research
into autism, and the pioneering
subjects are just six months old.

RESOLVING THE MYSTERIES OF

AUTISM
The infants arrive in the evening
to be rocked and cuddled by their
parents, then put comfortably to
bed—in the bore of the scanner.
For as long as 10 days before their
imaging appointment, the infants
have become accustomed to the
subdued knock, buzz, and beep of
the high-tech imager as their parents have played them a tape of the
noises they'll hear during the scanning process. The babies wear little
earplugs, under noise-shielding
headphones. And after they're
deeply asleep and perfectly still,
late-night scans record exquisitely
detailed images of their heads and
brains. They are exposed to no
radiation and need no anesthesia
or injection of contrast agents.
The research is so noninvasive
and unobtrusive that the babies
often sleep right through it. If they
fuss a little, the scanning pauses; if
ley wake, the session ends. Their
parents agree to participate even
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though they probably have their
hands full with both an autistic
child and a new baby. That's one
measure of how deeply committed
they are to resolving the mysteries
of autism.
DIAGNOSTIC IMAGING AND
EARLY INTERVENTION

The infants offer invaluable
insights to the research team
because, first, they are siblings
of children
diagnosed
with autism
and, due to
autism's
genetic component, are
far more
likely to
develop the
disorder
than are the
population at
large. The
tender age of
the subjects
is also crucial because
autism is
"clearly a
problem of
early brain development," says
Kelly Botteron; MD, associate professor of psychiatry and of radiology. "Early intervention is where
the future of autism treatment lies."
Today, by the time a diagnosis
of autism is stable, the effectiveness of intervention may already
have been limited. To help
change that, the youngsters are
participating in a five-year
national study funded by the
National Institutes of Healthsponsored Autism Centers of
Excellence (ACE) Network.

Summarizing the goal of the
research, Botteron, the principal
investigator of its St. Louis arm,
says it will "relate images of the
infants' developing brains to the
diagnosis of autism," helping to
understand the underlying neurophysiology and provide a target for
further research. "A study connecting imaging to diagnosis has never
been done in infants before,"
she says.

l\%

Kelly Botteron, MD: "MRI offers the unique opportunity to noninvasively study structural and functional
neural development in vivo in young children."

The children—who will be
scanned at six months, 12 months,
and 24 months of age—will be
joined by a control group of identically aged, healthy youngsters with
no predisposition to autism. All of
the youngsters will likewise be
carefully tested to either make a
diagnosis of autism or rule it out.
Any abnormalities revealed by the
scans can then be associated with
developing autism and perhaps to
the wider range of related disorders

MALLINCKRODT INSTITUTE OF RADIOLOGY
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known as autism spectrum disorders (ASD), providing new insights
into those conditions as well.
Because the brain is developing so
rapidly during these early days of
life, the researchers face the challenge of making sure all subjects
are scanned and cognitively tested
within a week of the designated
birth
anniversaries. In
fact, the
researchers
say that the
rate limiting
factor in
what they
will be able
to learn is
their ability
While this MRI scan was being
to
recruit
done, the sleeping infant quite
participants,
naturally was sucking his thumb.
and they ask
for help in spreading the word
about their need for families that
have infants or babies on the way
and an autistic older child.
Previous studies of head circumference have demonstrated a
relationship between general brain
overgrowth and autism, Botteron
says, but despite increasing interest
in understanding autism, sophisticated imaging studies have been
surprisingly few. In fact, until
recently, many researchers believed
it was not possible to get accurate
and reliable images of such tiny
and sometimes uncooperative
subjects, she says.
ADVANCED TECHNOLOGY
The techniques the investigators
will use to safely and effectively
image the young subjects have been
developed over years of experience
at Washington University and
Mallinckrodt Institute. Robert
McKinstry, MD, PhD, associate
professor of radiology and of pediatrics, participated in devising the
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ABOUT AUTISM
Autism is a neurobiological developmental disorder usually diagnosed by three years of age. It interferes with a person's ability to
communicate, the capacity to relate to others and cognitive function.
Those with autism often display repetitive motions and follow rigid
routines. Autism carries a strong genetic component, but the genetics
of the disorder are complex and not well-understood.
It lasts throughout a lifetime but does not shorten life expectancy,
although people with autism often suffer from a number of physical
ailments including recurring infections, asthma, and digestive
disorders. There is no cure, but early intervention can reduce the
severity of symptoms, and behavioral or cognitive intervention can
help children gain self-care, social, and communication skills.
Autism is one of a group of disorders known as ASD, for autism
spectrum disorders, with a wide range of symptoms and severities.
Together, autism spectrum disorders affect an estimated 1.5 million
Americans, according to the Autism Society of America (ASA).
Controversy exists over just how rapidly the incidence of autism is
increasing. Improved diagnostic procedures contribute to larger
numbers, but there also appears to be an actual rise in the number
of cases. According to the group Autism Speaks, prevalence has
risen until one in every 150 children is diagnosed with autism,
making it more prevalent than pediatric cancer, diabetes, and AIDS
combined. It affects boys disproportionately.
A diagnosis of autism can be life changing for a family; frequently,
one parent must devote full time to providing care. The lifetime cost
of that care has been estimated at between $3.5 million and $5
million. In the United States, all autism-related expenses may be as
high as $90 billion annually, according to the ASA.
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RESOLVING THE MYSTERIES OF

AUTISM
sedative-free scanning of infants
during a 1999 to 2007 national MRI
study of normal brain development. So far in the autism study,
the protocol has been used to scan
the first five young subjects, with
unqualified success.
McKinstry, who is chief of
Mallinckrodt Institute's Pediatric
Radiology section, also designed
the imaging protocol and scanning
implementation for the autism
study. High-speed MRI is capable
of structural neuroimaging—the
capacity to visualize parts of the
brain such as the amygdala and the
frontal centers where facial processing occurs, both areas of concern to autism researchers. The
technology reveals the volume and
shape of the brain's gray matter,
made up of nerve cell bodies.
But the latest evolution of
sophisticated MRI technology,
called diffusion tensor imaging

mi

(DTI), goes a big step further. DTI
reveals the secrets of white matter,
the long tentacles of nerve cells
(or axons) that compose the wiring
connecting the various parts of the
brain. "DTI images the microstructure that carries signals, showing
whether the wires are properly
organized, aligned, and insulated,"
McKinstry says. "We can follow
them from one point in the brain
to another and test whether the
connections play a role in autism."
DTI uses radio waves and
magnetic pulses to nudge water
molecules in the brain. Water in the
axons is constrained by the myelin
sheaths that protect them, much
like a wire's insulation, so it tends to
move along the wire rather than dispersing in every direction like water
molecules elsewhere. By making
images of the water's organized
movement, investigators can map
the wires and locate their terminals.

A COLLABORATIVE EFFORT

The researchers will make
scans of the 100 infants with autistic older siblings whom they hope
to enroll in St. Louis, plus the
control group. Similar efforts at the
University of North Carolina, the
University of Washington at Seattle,
and the University of Pennsylvania
will bring the total number of
infants scanned to 400, along with
160 healthy, contrast subjects.
The large majority will not go on to
develop autism, but perhaps 60 of
the youngsters are expected to be
diagnosed with the disorder, given
established statistics. Data from
the four centers then will be
collected and analyzed at two
additional coordinating centers at
the Montreal Neurologic Institute
and the University of Utah. To
recruit qualified participants who
can visit at precise times requires a
region-wide effort, Botteron says,
and support groups such as Autism
Speaks are helping by alerting their
highly motivated members.
CHALLENGES AND
POSSIBLE SOLUTIONS

I

Another challenge faced by
the researchers is making accurate
autism diagnoses at very young
ages. John Constantino, MD, who
brings a large autism research portfolio to the study, says that many in
the field believe that the symptoms
of autism must be appreciable at
even six months, but "we're just
not sure." For those youngest children, he will observe and archive
video recordings that can be revisited for even the most subtle clues.
And he will use the still-face paradigm, in which a caregiver who has
been interacting with a child
quickly disengages; the sudden

Mfe
Left: In this autism study, Dr. Robert McKinstry
combines his clinical interest in pediatric
neuroradiology with his expertise in MRI.
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indifference upsets most normal
babies, but autistic infants often
are not bothered, he says. Constantino, associate professor of psychiatry and of pediatrics, says the
researchers also may be able to
employ eye-tracking technology to
measure precisely where babies
focus their attention for a "finergrained evaluation." A broader
range of established tests will be
used to evaluate the subjects as
they reach 12 months and 24
months of age. Finally, Constantino
will make a firm diagnosis when
the subjects reach three years, the
age at which diagnoses are widely
regarded as stable.

The researchers' hope for
the work is that it will produce
observable differences in the
brains of autistic children that can
serve as a basis for discerning the
mechanisms by which the disorder
develops. McKinstry says that,
ideally, the study could lead to a
diagnostic tool to be used as a
means to assess children who may
be at risk and even become the
basis for developing strategies to
4r
limit disability.
More likely, Botteron says, is
that the research may eventually
help to sort out the effectiveness
of the wide range of treatments
and interventions that are available. Families have several broad
varieties and dozens of individual
The Brain
plans from which to choose
when considering treatment.
"Many of the approaches are
untested, and it would be
helpful to know which
ones work," she says. Any
treatment shown to be
symptomatically effective
could be evaluated using
Putamen
the study's results to see
if underlying physiologiGlobus pallidus
cal changes are affected
Mammillary body
by a given treatment.
For example, the wellregarded approach called
applied behavioral
analysis (ABA) that is
generally regarded as a
T" Spinal cord
successful treatment
approach could be tested
irain as viewed from the underside and front. The thalamus and Corpus Striatum
to reveal if and how the
jmen, caudate and amygdala) have been splayed out to show detail.
underlying physiology is
rpus Striatum
normalized as the treatiudate
ment progresses.
ucleus

Botteron warns that the size
of the sample of children who
eventually develop autism—
perhaps 60—is small and that
autism is aggravatingly complicated,
most likely
attributable to
several or even
many causes,
and with a
wide range of
symptoms and
severities.
For one study
to unravel all
of its complexities is not
possible.
Nonetheless,
"families are
desperate for
4
something to
help," Botteron
says, and the
young volunteers who go
John Constantino, MD, has
to sleep in
more than 10 years experiMallinckrodt
ence in autism research.
Institute's
scanner are providing a first look
at the condition as it develops—a
big step in a promising new direction before they can even walk. Ed
Editor's Note: For more information about participating in this
important study, go online at
http-Mnfantsibs-stlouis.org. Or
call Study Coordinator Lisa Flake,
MSW, toll free at 1-888-845-6786.

Lenticular nucleus
(globus pallidus
and putamen)
Amygdala
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The National Oncologic
IMPORTANT
PET Registry AN
MILESTONE
by Candace O'Connor

egistry (N(
began accruing patients in May 2006, has reached an
important milestone with exciting results. In March
_*■

2008, the NOPR announced that, based on the findings

of PET scans performed with the radiotracer F-18 fluorodeoxyglucose
(FDG), clinicians at more than 1,200 facilities around the
country—participants in this sweeping effort to measure the effect
of positron emission tomography (PET) findings on treatment
decisions—had changed the care of 36.5 percent of the 23,000
registered cancer patients.
Now this data has been submitted to the Center for Medicare
and Medicaid Services (CMS), which will begin a review process
to determine whether these findings should lead to coverage of
more forms of cancer. Currently, CMS only covers PET scans for
certain cancers—ovary, uterus, prostate, pancreas, bladder, kidney,
stomach, and others-|-among patients who receive their scans at
facilities that participate in the Registry.

The impact of FDG-PET
comes as no surprise to
Arizona resident Laurel
Pracht, now 62, who was
diagnosed with late-stage ovarian
cancer in 1999. She had surgery
and chemotherapy, but it was hard
to determine whether she had
residual cancer because her tumor
did not express the usual tumor
marker, CA-125. When Pracht's
oncologist warned her to get her
affairs in order, based on the findings of a computed tomography
(CT) scan and an elevated tumor
marker, she paid the out-of-pocket
cost for a PET scan that showed no
cancer! A sixth round of planned
chemotherapy was canceled.
In a later
episode of
suspected
recurrence—
covered this
time by the
Registry—
PET again
came to
the rescue,
showing that
Pracht was
cancer-free.
During the
years before

l#*

?

uurel Pracht: I would not
have pad for my own PET scans
had I not thought the results
would d.rectly assist in the
management of my disease."

^ Registry,
ghe h&d
paidoutof
pocketfortwo
pET gcans

"My survival is due to skilled
medical care, a good response to
chemotherapy, being an educated
patient, and not being denied PET
scans, proven in my case to be
cost-saving and accurate," says
Pracht, a vocal advocate for PET
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scan coverage. "Cancer patients
should not be more concerned
about making an installment payment on the cost of a scan than
about how long they have to live."
Mallinckrodt Institute's Role
The success of the NOPR in
completing this innovative "coveragewith-evidence-development" study
also comes as no surprise to Barry
Siegel, MD, cochair of the NOPR
working group. Siegel, professor
of radiology and of medicine, has
been a key advocate and organizer
of the NOPR, which was sponsored
by the Academy of Molecular
Imaging (AMI) and managed by
the American College of Radiology
through the American College of
Radiology Imaging Network
(ACRIN). He believes that the
Registry's decisive results should
substantially change the coverage
policy of CMS, which is now
reviewing the NOPR data in a
process that includes a six-month
analysis to produce a draft decision,
then another analysis period to
create a final decision.
"The NOPR was launched successfully, has accrued successfully,
and has made PET accessible to a
large number of patients," says
Siegel, who is also deputy cochair
of ACRIN and medical director of
its PET Imaging Core Laboratory.
"We believe it has generated
compelling data that we hope will
convince Medicare that much
broader coverage of PET than
is currently available is indeed
reasonable and necessary."
On March 24, Siegel and his
colleagues published their findings
in the on-line version of the Journal
of Clinical Oncology; the print
version appeared on May 1. Also
in March, they submitted a reconsideration request to CMS, asking

Barry Siegel, MD: "The ultimate accomplishment would
be broad coverage for diagnosis, staging, and restaging
for all cancers as well as treatment monitoring."

the agency to provide coverage for
the diagnosis, staging and restaging
of all cancers except three, already
listed as "nationally non-covered":
diagnosis of breast cancer when
an abnormality is present by
mammography or palpation, and
regional node assessment in breast
cancer, and malignant melanoma.
Background of the Study
While other forms of imaging—
especially magnetic resonance
imaging (MRI) and CT—have long
been covered for cancer patients,
PET has not. More than a decade
ago, the agency that preceded CMS
in administering Medicare
considered covering PET broadly
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but decided against it, because it
was concurrently adopting regulations that would require scientific
evidence to prove that new technologies improved patient outcomes.
So the agency instead decided
to approve PET only for certain
types of cancer:
• 1998—evaluation of lung nodules
and the initial staging of non-smallcell lung cancer
• 1999—restaging of patients with
recurrent colorectal cancer, some
lymphoma cases, and possible
recurrence of melanoma
•2000—diagnosis, staging, and
restaging of non-small-cell lung
cancer, lymphoma, malignant
melanoma, esophageal cancer,
colorectal cancer, and head-andneck cancer
•2002—partial breast-cancer
coverage
•2003—partial coverage for restaging
of various thyroid cancers.
Still, many physicians felt
frustrated by these limitations
since they believed in a much
broader use of PET; in 2002 the
AMI acted, encouraging medical
centers to petition for more coverage. Nine institutions responded,
including Mallinckrodt Institute,
where Siegel and Perry Grigsby,
MD, professor of radiation oncology,
of radiology, and of obstetrics and
gynecology, requested coverage for
cervical cancer. In 2004, CMS

decided to approve only cervical
cancer, but the agency also
announced that it would consider
covering other cancers as part of a
large-scale "coverage-with-evidencedevelopment" effort to evaluate
PET's effectiveness.
How the NOPR Worked
Siegel and his colleagues began
discussing this idea and came up
with the plan for a registry. They
contacted the American College of
Radiology and asked whether its
imaging network, ACRIN, could
provide the necessary infrastructure. Other key groups, including
the American Society of Clinical
Oncology and the Society of
Nuclear Medicine, also offered
support. Substantial funding came
from the AMI, through its Institute
for Molecular Technologies.
Medicare-eligible patients
could participate when they came
in with a referral for a PET scan
to evaluate a form of cancer not
otherwise covered by Medicare.
Before the test, the facility had to
collect, from the referring physician,
a pre-PET questionnaire, indicating
planned treatment without PET
data; afterwards, another questionnaire assessed the physician's
treatment plan in light of FDGPET findings. All information was
collected electronically through
the NOPR Internet site.
The NOPR organizers spent
hours educating PET facility
personnel and referring physicians
about data collection and about the
uses and misuses of PET. Despite
minor bumps, the process went
"quite smoothly," says Siegel. "It
exceeded our expectations as to
how smoothly it ran."

PET and Cancer
Although FDG-PET is a valuable
tool in diagnosing or staging certain forms of cancer, says Siegel,
there are forms of cancer in which
it may be less sensitive than other
imaging methods. It does not do
particularly well with the diagnosis
or initial staging of prostate cancer,
liver cancer, or "mucinous cancers"
such as stomach cancer.
Yet in this study, "we have
drilled down and do not find that
there are any cancers for which
PET is an exceptionally outstanding
performer or exceptionally poor
performer in terms of changing
management," he says. Overall, he
believes it is an effective tool for
many cancers, so Medicare should
trust physicians, and the radiologists
who advise them, to understand
PET's limitations and to use PET
whenever appropriate.
In this study, PET also showed
one surprising result in patients for
whom a biopsy was being planned
to evaluate their cancers. In some
three quarters of these patients, the
PET scan eliminated the need for
this procedure.
Does PET save lives?
Although the NOPR findings
demonstrate that PET has a substantial effect on the way in which
physicians treat cancer patients,
does that translate into more lives
saved? Intuitively, most people
might guess that it does. But so far,
says Siegel, no hard data exist to
show that using PET leads to a pro-
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longed life span for cancer patients.
Existing studies do show that
PET allows doctors to find certain
recurrent cancers at an earlier-and
presumably more treatable-stage
than they would have been otherwise. In fact, this early detection
has sometimes allowed surgeons
to perform a complete surgical
removal of the recurrence.
Clearly, PET also has another
advantage: It gives both physicians
and patients the chance to "conserve resources." For example,
pancreatic cancer, caught early
enough, can be treated surgically
with the "Whipple procedure," an
extensive operation with a difficult
recovery period.
"But if you look at the PET
scan, and find that the patient has
distant metastatic disease, then
PET findings have steered the
patient away from radical therapy
that is intended to be curative but
that cannot be curative," says Siegel.
In the future, PET may also be
useful in the area of treatment
monitoring. After a patient has had
one or more cycles of chemotherapy, what effect is it having? It
may be too early for CT scanning
to have shown any response. By
assessing the cancer's metabolism
rather than its size, PET is usually
able to determine early on if the
drug is not working, thus conserving
expensive medications, conserving
the patient's strength, and allowing
the patient to shift to a drug therapy
that may work better.
"That is the whole concept of
using molecular imaging for what
has been called individualized medicine but may be more correctly
labeled 'risk-stratified medicine,'"
says Siegel. "We may not be certain
that our answer will work for a
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patient all of the time, but we
enrich the probability that it is the
right one because we have shown,
metabolically, that the patient is in
the responder group rather than
the non-responder group."

The NOPR Working Group
- Barry Siegel, MD, professor of radiology and of medicine; chief, Division of
Nuclear Medicine—Mallinckrodt Institute of Radiology at Washington

Future of NOPR Findings
The CMS review process
should be complete by January
2009, with a report issued detailing
the new guidelines. Meanwhile,
CMS coverage of PET scans for
cancer patients who have Medicare
coverage continues during the
more than 87,700 patients have
received scans covered under the
Registry to date.
The NOPR working group is
hopeful about the outcome, and
patients like Laurel Pracht are
eager for a positive decision.
Within her on-line support group of
ovarian-cancer survivors, some
have had PET scans that changed
their course of treatment. "Others
have died, while making installment payments on the cost of their
scans," she says.
"Doctor Siegel has stayed the
course, taking the NOPR from an
idea to the first collaboration
between the private medical imaging sector and CMS," says Pracht.
"He and the committee were fully
aware that patients were divided
into those who could afford the outof-pocket cost for this diagnostic
tool and those who could not-and
they have directly benefited this
patient's future." EM

University School of Medicine
• Edward Coleman, MD, professor of
radiology; chief, Division of Nuclear
Medicine—Duke University School of
Medicine
• Bruce Hillner, MD, professor of
internal medicine; associate chair,
information systems—Virginia
Commonwealth University
• Anthony Shields, MD, PhD, professor of
medicine and of oncology—Wayne
State University; director, clinical
research—Karmanos Cancer Institute,
Detroit, Michigan
• The Statistical Center—Brown University.
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RADIOLOGY IN THE ROUGH

ON DUTY IN IRAQ
by Mary Jo Blackwood, RN, MPH

Most radiologists at Mallinckrodt Institute of Radiology (MIR) probably
don't think twice about the diagnostic technology available at MIR—
they're accustomed to having multiple units of cutting-edge equipment
on hand to provide the highest quality care for patients. Matthew
Parsons, MD, assistant professor of radiology in the Institute's Neuroradiology section, now has a new appreciation for these ready
resources after his stint in Iraq at the 325th Combat Support Hospital
(CSH, pronounced "CASH").

I
"We did our work at the hospital
with two CT [computed tomography]
scanners, an X-ray unit, and an
ultrasound," says Parsons. "There
was no MRI [magnetic resonance
imaging] or PET [positron
emission tomography]."
Parsons joined the Army
Reserve in September 2000, was
activated in August 2007 and sent
to Iraq. He served 100 days as the
only radiologist in the hospital at
Al Asad (Arabic for "The Lion") Airfield, approximately 180 kilometers

west of Baghdad and the largest
United States military airbase in the
mostly Sunni-populated, western
Iraq province of Al Anbar. When
Parsons arrived at the hospital and
met the radiologist he was replacing, they discovered they had been
medical students together at the
University of Cincinnati. Radiologists,
a scarce specialty in the military,
are required to serve for 100 to 110
days during one stint, with probable redeployment of 18 months to
two years between tours of duty.
Left: Parsons' office was a
subdivided module, containing
a desk and two laptops for
viewing digital radiology images.
Below: Abraham's Well at Al
Asad: According to theologians,
Abraham—who is referenced in
literature of the Muslim, Jewish,
and Christian religions—stopped
at this oasis while travelling
from Mesopotamia (modern-day
Iraq) to the land of Canaan.
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AL ASAD AIR BASE
The 325"1 is the primary United States
military healthcare facility in Al Anbar
province, the site of nearly 40 percent of
all United States casualties in the Iraq war.
Before the 325th opened, patients requiring
Level III surgical care had to be evacuated
to hospitals in Baghdad, Iraq's capital, or
Balad, a primarily Shiite town 50 miles
north of Baghdad. The 325,h's location
significantly decreased amount of time
it took to get patients to an advanced
surgical and stabilization care facility.
The first pieces of the 32-bed hospital
arrived in Al Asad in January 2007. The
modular structure allowed for rapid
construction, and the facility was finished
in about two months. It was the first
United States medical facility to be built
from the ground up in Iraq. The hospital's
constructed from separate modules
hooked together; the modules can be
subdivided by adding walls to make
additional rooms. Interior walls are similar to dry-erase boards and are often used
for recording patient care information.
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Above: Helicopters bring the wounded and those needing
medical care to the 325th CSH.
Photos courtesy of Matthew Parsons, MD
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ON DUTY IN IRAQ

ON THE JOB

The 325'" is staffed by United
States military and, according to
Parsons, the only Iraqi nationals
who work there serve as translators. Parsons'job description was
simple: interpret all films and be on
call 24/7. While stationed at Al Asad,
he received and read films transmitted by satellite from Tikrit Airbase
(100 miles northwest of Baghdad)
and handled trauma cases.
While he may not have had as
much equipment as is readily available at Mallinckrodt Institute, the
equipment Parsons did have saved
lives. "Radiology is crucial to survival in Iraq. For example, when
people were brought to the hospital
after being injured by a car bomb
or by a suicide bomber wearing an
IED [Improvised Explosive
Device], I could determine the
extent of the injuries and if surgery

Each choo is roughly eight feet by sixteen feet and
has one window and one door.
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was needed," says Parsons. "The
hospital there couldn't function
without radiology; its absence
would result in more—and perhaps
less accurate—surgery being done.
I could tell the surgeons where the
fragments were, which could
decrease the need for exploratory
surgery, or I could pinpoint the surgical target. Our CT scanners were
crucial for that job. With diagnostic
imaging, it was possible to pinpoint
the shrapnel relative to sensitive
structures, so we could determine
whether surgery was required."
"Our rule for accepting people
at the hospital: If life, limb, or
eyesight was at risk, they were
seen. That included United States
service men and women, Iraqi
soldiers, Iraqi civilians, government
contractors, and people from other
countries who happened to be there."
The hospital also ran an outpatient
clinic for noncombat-related minor
injuries, which often included
sports injuries from running, basketball, football, or soccer. Imaging
helped to nail down the causes and
treatment options.
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LIFE ON THE BASE

Most of the housing units on
base are called "choos," explains
Parsons. "The choo that I shared
with another doctor had two beds,
two desks, a TV, and a DVD player.
We had satellite cable for the
Armed Forces Network, so we got
Monday Night Football on Tuesday!
There was also an Internet connection. And, we had an air-conditioner,
which is pretty much a necessity
when you're living in a metal box in
a country where the daily temperature
can reach 130 degrees Fahrenheit.
The hospital and the two large dining
facilities also were air-conditioned."
Commuting to work was no
problem. "My living quarters were a
quarter of a mile from the hospital,
and the two dining facilities were

each about one mile away. The
highlight of my day was lunch and
dinner," Parsons says with a smile.
"I walked everywhere and felt very
safe, partially because all personnel on the base are required to
carry side arms."
Parsons took his laptop computer and a digital camera to Iraq,
so he could send pictures home
over the Internet. He was able to
call his wife almost everyday. "The
only exception was when a soldier
died," Parsons says. "No one was
allowed to send e-mails or call
home until the military had notified
the soldier's family in the correct
compassionate way." Once a week,
Parson had a video conference call
with his wife and 14-month-old son
Jack. "My wife said that because of
the video calls, Jack thought his
daddy lived in the computer."

RADIOLOGY CASES FROM AL ASAD
Head CT scan of a
latient who was
'njured by an
Improvised Explosive
Device (IED) blast.
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CT scan of a Marine,
with symptoms of
nausea, vomiting,
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n the frontal lobe
of his brain. He
was transferred to
a hospital in
the States.
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Left: This house belonged to a date farmer
whose land was confiscated during Sadaam
Hussein's presidency; the land became part
of an Iraqi Air Force base called Al Asad.

TEAMWORK
When asked about his memories of his time in Iraq, Parsons says
that it is hard to forget the extreme
heat and that all the surroundings
seem to be in shades of tan or
brown, no greenery or color. "But I
think mainly it's the doctors I
worked with," he adds. "We really
were a team. I keep in contact with
some of the other physicians; one
of them from San Francisco came
here for a visit. They were very
professional and treated everyone
with the same courtesy and care—
military officers and Iraqi citizens
alike. It was a great example of
the phrase: 'Medicine knows
no boundaries.'" EH
Matthew Parsons, MD, (kneeling, fifth from the left)
and the physicians of the 325th Combat Support
Hospital, Al Asad.

I
A MEMORABLE CASE
A young Marine and his canine
partner, Leah, were on patrol in
Fallujah, about 40 miles west of
Baghdad, when a suicide bomber
detonated an IED next to them.
Most of the bombers fill their vests
with either nails or ball bearings to
do the most damage—this one had
used ball bearings. "The Marine
had facial injuries," says Parsons.
"We used CT to scan his head,
neck, and face,
which showed
V
that a ball bearing had fractured
*«
his mandible and
was lodged near
the carotid artery.
CT of the young Marine
shows the ball bearing
lodged near the internal

The CT scan located the ball
bearing so precisely that we
were confident it could safely
be left in place without causing
more injury. It saved the
Marine from having exploratory
surgery to a delicate area."
Leah, on the other hand,
seemed to have only superficial
wounds on the chest and
abdomen, but she was acting as
though she was badly injured.
"So I performed my first ever
CT scan of a dog and discovered she had a ruptured spleen
and damaged bowel," says
Parsons. Leah was taken to the
OR so surgeons could repair the
bowel and remove the spleen.
The dog recovered but was
retired from active duty and
returned to the States.

I
u
Above: An anesthesiologist readies Leah
for a CT scan.
CT scan reveals blood
around Leah's spleen,
which was severed into
two parts.

carotid artery.
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In this section, the names of employees who are full-time
faculty or staff or who have an appointment in the
Department of Radiology are highlighted in boldface type.

NEW FACULTY
Kristopher Cummings, MD,
instructor in radiology, Division of Diagnostic Radiology.
Michelle Lee, MD, instructor in radiology, Division of
Diagnostic Radiology.
Nael Saad, MD, instructor
in radiology, Division of
Diagnostic Radiology.
Darryl Zuckerman, MD,
assistant professor of radiology, Division of Diagnostic
Radiology.

JOINT
APPOINTMENT
Carolyn Anderson, PhD,
professor of radiology, of
molecular biology and pharmacology, and of chemistry,
was appointed professor of
biochemistry, Department of
Biochemistry and Molecular
Biophysics.

GRANTS
Kevin Black, MD, associate
professor of psychiatry, of
neurology, of radiology, and
of anatomy and neurobiology,
received a one-year grant in
the amount of $61,825 from
the Tourette Syndrome
Association for "Finding tics
in the community without
f putting a doctor on every
corner." He received a one-
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year grant from Synosia
Therapeutics for "A randomized, double-blind, placebocontrolled, two-way cross-over
study to explore the effects
of 7 days dosing with
SYN115 20mgp.o. BID or
60 mg p.o. BID on clinical
and fMRI response to intravenous levodopa in patients
with mild to moderate
Parkinson's disease."
Colin Derdeyn, MD,
professor of radiology, and
of neurology and neurological
surgery, is the principal
interventional neuroradiology
investigator for a $27 million
grant from the National
Institute of Neurological
Disorders and Stroke
(NINDS) for research on
"Stenting vs. aggressive
medical management for
preventing recurrent stroke
in intracranial stenosis
(SAMMPRIS)." Marc Chimowitz, MBChB, Medical
University of South Carolina,
is principal investigator for
the five-year multicenter
study. Derdeyn serves as
chair of the Advisory Committee for the six-year,
$1.9 million NINDS-funded
"Vertebrobasilar flow evaluation and risk of transient
ischemic attack and stroke
(VERITAS) Study." Sepideh
Amin-Hanjani, MD, University
of Illinois, Chicago, is principal investigator. Derdeyn is
coinvesrjgator for the four-year,
$4.2 million NINDS-funded
"Carotid occlusion surgery
study." Principal investigators are William Powers, MD,
University of North Carolina,
and Robert Grubb, Jr.,
MD, professor of neurological surgery and of radiology.

Robert McKinstry, MD,
PhD, associate professor of
radiology, is the study center
principal investigator for the
American College of Radiology Imaging Network (ACRIN)
Protocol 6677 "Staging with
MR perfusion imaging and
MR spectroscopy." ACRIN
6677 is being conducted in
collaboration with the Radiation Therapy Oncology
Group Protocol 0625, "A
randomized phase II trial
of bevacizumab with
temozlomide in recurrent
glioblastoma." Funding for
the study is on a per-subject
basis, with current funding
at $34,174.
Suresh Vedantham, MD,
associate professor of
radiology, as principal investigator, received a five-year,
$7.2 million grant from the
National Heart, Lung and
Blood Institute, National
Institutes of Health, for
research on "Pharmacomechanical catheter-directed
thrombolysis for acute DVT."
Karen Wooley, PhD, professor of chemistry and of
radiology, received a threeyear grant in the amount of
$443,917 from the Office of
Naval Research for "The
development of non-toxic
anti-fouling coatings based
upon nanoscopic surface
complexities." She is a coinvestigator for a five-year
grant in the amount of $9.3
million from the National
Institutes of Health for
research on "Targeted
nanoparticles optimized
for cancer diagnosis and
therapy." She is a coinvestigator for a five-year, $1.9
million grant from the
National Institutes of Health
for research on "Adhesinbased nanotherapeutics in
urinary tract infection."

APPOINTMENTS/
ELECTIONS
Deanna Barch, PhD,
associate professor of
psychology, of psychiatry,
and of radiology, was named
director of the Silvio Conte
Center for Neuroscience
Research at Washington
University in St. Louis.
Mikhail Berezin, PhD,
instructor in radiology, was
appointed to the program
committee for the 2009 SPIE
International Symposium of
Biomedical Optics.
Colin Derdeyn, MD,
professor of radiology, and
of neurology and neurological
surgery, was appointed to
the Clinical Neuroscience
and Disease Study Section
of the National Institutes of
Health's Center for Scientific
Review. He was appointed to
a four-year term as a consultant to the Neurological
Devices Panel of the Medical
Devices Advisory Committee
of the Food and Drug Administration's Center for Devices
and Radiological Health. He
also was appointed to a fiveyear term on the Steering
Committee of the National
Institute of Neurological
Disorders and Stroke
Specialized Programs for
Translational Research in
Acute Stroke (SPOTRIAS)
Center Network.
Joel Perlmutter, MD,
professor of neurology, of
radiology, and of physical
therapy, was appointed to
the Advisory Board of the
Bauder Center for Business
Medical Ethics at Saint
Louis University, St. Louis,
Missouri.
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APPOINTMENTS/
ELECTIONS
Continued from page 27
Fred Prior, PhD, research
associate professor of radiology, was appointed chairman
of the Georgetown University
Biomedical Informatics
External Advisory Board.
Brian Rubin, MD, PhD,
professor of surgery and
associate professor of radiology, was elected president of
the Midwestern Vascular
Surgical Society.
Barry Siegel, MD, professor
of radiology and of medicine,
was appointed deputy
cochair of the American
College of Radiology Imaging
Network (ACRIN) and was
reappointed as medical
director of the ACRIN PET
Imaging Core Laboratory.
Marilyn Siegel, MD,
professor of radiology and
of pediatrics, was appointed
chair of the Radiology
Committee of the National
Cancer Institute's Children's
Oncology Group.

Pamela Woodard, MD,
associate professor of radiology, was appointed chair of
the American College of
Radiology Imaging Network's
newly formed Cardiovascular
Imaging Research Committee.

LECTURES
Carolyn Anderson, PhD,
professor of radiology, of
molecular biology and pharmacology, and of chemistry,
presented "New radiopharmaceuticals for oncological
imaging" at the Society of
Nuclear Medicine Mid-Winter
Meeting, Newport Beach,
California, February 16.
She presented "Copper-64labeled biomolecules for
molecular imaging of cancer
metastasis" at the Department
of Chemistry, Virginia
Commonwealth University,
Richmond, April 17.

Kevin Black, MD, associate
professor of psychiatry, of
neurology, of radiology, and
of anatomy and neurobiology,
presented "Dopaminergic
modulation of working memory in Tourette's syndrome"
at the American Neuropsychiatric Association's 19"'
Annual Meeting, Savannah,
Georgia, March 1-4.
Jeffrey Brown, MD, professor of radiology, spoke on
"MR contrast agents: a brief
history" at the Nebraska
Radiological Society, Omaha,
April 23. He presented
"Gadolinium-based contrast
agents: summary of existing
knowledge on NSF" at the
University of Nebraska Medical Center, Omaha, April 24.

Carmen Dence, MS,
research associate professor
of radiology, spoke on "PET
imaging in nuclear chemistry—role of radiopharmacy
and applications to nuclear
medicine" at Atlantico
University, College of Pharmaceutical Chemistry,
Barranquilla, Colombia,
February 8. She presented
"PET imaging in nuclear
chemistry—applications to
nuclear medicine" at the
National Cancer Institute,
Bogota, Colombia, February
13. As keynote speaker,
Dence presented "Role of
radiopharmacy in PET imaging and radiochemistry" and
"Comparison of national
PET radiopharmaceutical
regulations" at the 5th
National Congress of Hospital Pharmacy, Bogota,
Colombia, March 7 and 8.

Kyle McCommis, research technician, Division of Radiological Sciences, as lead author, received the Young

Jerold Wallis, MD, associate
professor of radiology, was
appointed to the Board of
the Intersocietal Commission
for the Accreditation of
Nuclear Medicine
Laboratories.

Investigator Award for his presentation on "Detection

Karen Wooley, PhD,
professor of chemistry and
of radiology, was appointed
to the Review Committee on
Faculty Personnel Procedures, Washington University,
St. Louis, Missouri.

Friedrich, MD, SCMR program chair, and Stefan

of changes in myocardiai blood flow and volume: a
CMR study in a canine model of coronary artery
stenosis" at the Society for Cardiovascular Magnetic
Resonance (SCMR) 11th Annual Scientific Sessions in
Los Angeles, California, January 31-February 3.
McCommis (left) accepts the award from Mathias
Neubauer, MD, SCMR president.
As lead author of "Quantification of myocardiai blood
volume during dipyridamole and dobutamine stress: a
perfusion CMR study," McCommis also received second-place recognition for the Gerald Pohost Journal of
Cardiovascular Magnetic Resonance (JCMR) Best
2007 Manuscript.
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Colin Derdeyn, MD, professor of radiology, and of
neurology and neurological
surgery, presented
"Overview of cerebral hemodynamics" at the 8Ul Annual
International Meeting on
Cerebral Revascularization,
St. Louis, Missouri, January
10. He spoke on "Natural
history of North American
Moyamoya disease" at the
10th Annual Joint Meeting of
the American Association of
Neurological Surgeons/Congress of Neurological Surgeons Joint Section on
Cerebrovascular Disease,
New Orleans, Louisiana,
February 18.
Igor Efimov, PhD, professor
of biomedical engineering
and of radiology, spoke on
"Biophotonic imaging of
atrial pacemaker complex"
at the Cardiovascular
Research Seminar, Washington University, St. Louis,
Missouri, January 24. He
spoke on "Electroporation in
the intact heart: implications
for defibrillation, arrhythmia
and stunning" at Medtronic,
Inc., Minneapolis, Minnesota,
January 28. He presented
"Mechanisms of ventricular
fibrillation and a new
approach to cardioversiondefibrillation," "New
approaches for the low
energy cardioversion and
defribillation," and "Basic
electrophysiological mechanisms of initiation of
supraventricular tachyarrhythmia" at the VIII Pan
Slavic International Congress on Cardiac Pacing and
Electrophysiology "CARDIOSTIM," Saint Petersburg,
Russia, February 15. Efimov
presented "Functional
anatomy of the AV junction"
at the Cardiac Bioelectricity
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and Arrhythmia Center,
Washington University,
St. Louis, Missouri, March
31. He presented "Molecular
and structural basis of
arrhythmia in the human AV
junction: insights from biophotonic imaging" at Cardiology Grand Rounds,
University of Cincinnati College of Medicine, Ohio, April
22. He spoke on "Translation
of basic cardiac arrhythmia
research from animal models
to clinical therapy: need of
the human heart research" at
Mid-America Transplantation Services, St. Louis,
Missouri, May 6.
Louis Gilula, MD, professor
of radiology, of orthopaedic
surgery, and of plastic and
reconstructive surgery, as
visiting professor, spoke on
"Analysis of complex carpal
trauma" and "Radiographic
entities to know that often
are not known" at the University of California, San
Diego, February 25 and 26.
As visiting professor, he presented "Radiology Board
Review in musculoskeletal
system" at the Oregon Health
and Science University,
Portland, April 16 and 17.
Fernando Gutierrez, MD,
professor of radiology, presented "Evolution of CT/MR
indications: pluses and
minuses"; "Cardiac anatomy
on MDCT/MR: normal variants"; "Chest pain in the
ED—the radiologist's role:
MDCT-triple rule-out?";
"Imaging congenital heart
disease in adults" and "Diseases of the pericardium" at
Non Invasive Cardiac Imaging Review: MDCT, ECHO,
MRI, presented by Mallinckrodt Institute of Radiology
and Somascan Medical
Imaging, San Juan, Puerto
Rico, February 16 and 17.

Jay Heiken, MD, professor
of radiology, presented "CT
colonography for colorectal
cancer screening: Is it practical?" at Practical Radiology
at Whistler 2008, sponsored
by the University of British
Columbia, Whistler, February
2-8. He presented "Imaging
evaluation of the living
related liver donor" at State
of the Art CT & MR, sponsored by the Society of Computed Body Tomography and
Magnetic Resonance,
Charleston, South Carolina,
March 30-April 4. As visiting
professor, he spoke on
"Acute mesenteric ischemia:
MDCT evaluation" and "CT
colonography for colorectal
cancer screening: current
status" at Brown University
Medical School, Providence,
Rhode Island, April 7.
Rebecca Hulett-Bowling,
MD, assistant professor of
radiology, as visiting professor, spoke on "Untwisting the
mystery of malrotation—Is it
possible?" at the University
of Arizona, Tucson, April 3.
Cylen Javidan-Nejad, MD,
assistant professor of radiology, spoke on "Coronary
CTA: How to do it"; "Coronary CTA: How to read it";
"CT/MR of myocardial diseases"; and "Cardiac valves:
MRI and echocardiography"
at Non Invasive Cardiac
Imaging Review: MDCT,
ECHO, MRI, presented by
Mallinckrodt Institute of
Radiology and Somascan
Medical Imaging, San Juan,
Puerto Rico, February 16
and 17.
Richard Laforest, PhD,
associate professor of radiology, presented "The three
photon yield from e+ annihilation in biological liquids" at
the American Physics Society
Annual Meeting, St. Louis,
Missouri, April 10-14.

Robert McKinstry, MD,
PhD, associate professor of
radiology, spoke on "Imaging
of brain injury in newborns"
and "Neuro cases from the
Mallinckrodt Institute of
Radiology" at Cincinnati
Children's Hospital Medical
Center, Cincinnati, Ohio,
March 7.
Mark Mintun, MD, professor of radiology, presented
"Patterns of [nC] PIB uptake
in non-demented subjects" at
the Human Amyloid Imaging
Conference, Chicago, Illinois,
April 11. He spoke on "New
directions in imaging—
changing how we see AD" at
the American Academy of
Neurology Corporate Therapeutic Update Symposium,
Chicago, Illinois, April 15.
Joel Perlmutter, MD, professor of neurology, of
radiology, and of physical
therapy, presented "Mechanisms of deep brain stimulation" at the Neuroscience
Research Seminar, University of Rochester, New York,
March 6. He presented
"Cerebral mitochondrial
function in PD and HD" at
Grand Rounds, University of
Rochester, New York, March
7. Perlmutter spoke on
"Investigations of deep brain
stimulation" at North Shore
University Hospital-LIJ Medical Center, Manhasset, New
York. He presented "PET
investigations of dopaminergic pathways," chaired "Integrated Neuroscience
Session: New methods in
imaging," and spoke on
"Starting a research career"
at the 60* Annual Meeting of
the American Academy of
Neurology, Chicago, Illinois,
April 12-19.
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LECTURES
Continued from page 29
Fred Prior, PhD, research
associate professor of radiology, presented "Integration of
images for knowledge discovery" and served as session
chair for the National Forum
on the Future of the Defense
Health Informatics, Washington, DC, March 26-28.
Barry Siegel, MD, professor
of radiology and of medicine,
spoke on "PET and PET/CT
in gynecologic malignancies"
and "Monitoring and predicting
tumor response to treatment
with PET and PET/CT" at
Advances in Diagnostic and
Interventional Radiology
Symposium, sponsored by
King Faisal Specialist
Hospital & Research Centre,

Riyadh, Kingdom of Saudi
Arabia, January 8-10. He
presented "Endocrine, RE,
non-imaging & lymphatic,
GI"; "PET & PET/CT coding
& reimbursement"; and "PET
coverage with evidence
development (CED) &
National Oncologic PET
Registry (NOPR)" at the
Society of Nuclear Medicine
Reimbursement Seminar,
St. Louis, Missouri, January
18. Siegel spoke on "PET in
gynecologic cancers" at the
PET/CT Oncology Symposium,
Philadelphia, Pennsylvania,
February 9. He presented
"PET in thoracic oncology"
and "PET in women's
diseases" at the Philippine
College of Radiology 2008
Annual Convention, Makati
City, Manila, Philippines,
February 21-23.

Marilyn Siegel, MD, professor of radiology and of
pediatrics, presented "CT
imaging of congenital heart
disease," "Magnetic resonance imaging of pediatric
bone marrow," "Advances in
cancer imaging," and "Ultrasound of pediatric spine" at
Advances in Diagnostic and
Interventional Radiology
Symposium, sponsored
by King Faisal Specialist
Hospital & Research Centre,
Riyadh, Kingdom of Saudi
Arabia, January 8-10.
She spoke on "Pediatric
renal masses," "Neonatal
hydronephrosis," "Renal
cystic disease," "Pediatric
pelvic masses," "CTA-MRA
of pediatric liver masses,"
"Imaging acute RLQ pain in
children," and "Pediatric
scrotal masses" at the Philippine College of Radiology

2008 Annual Convention,
Makati City, Manila, Philippines, February 21-23. Siegel
spoke on "CTA of mediastinal
vascular anomalies" and
"CTA of congenital heart
disease" at Current Concepts
in Imaging Course, sponsored
by the Uniformed Services
Hospital of the Health Services, Bethesda, Maryland,
March 2. She presented
"MDCT of adult congenital
heart disease" at the 31st
Annual Course of the Society
of Computed Body Tomography and Magnetic Resonance
Imaging, Charleston, South
Carolina, April 4 and 5. She
presented "Pediatric CT
angiography," "CT angiography of adult mediastinal
anomalies," and "CT angiography of adult congenital
heart diseases" at Advanced
Topics in CT Scanning: CT
Angiography, 3D Imaging,
Virtual Imaging Course,
sponsored by Johns Hopkins
University, Las Vegas,
Nevada, April 12 and 13.
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Above: Marilyn Siegel, MD, and Barry Siegel, MD, (left) shown with other attendees at an
evening event that was part of the symposium sponsored by King Faisal Specialist Hospital
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& Research Centre in Riyadh, Kingdom of Saudi Arabia.
Right: Marilyn Siegel, MD, wearing a rhinestone-adorned

ODOVB,

the traditional outer

garment that is mandatory attire for all women in Saudi Arabia.
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Franz Wippold, MD,
professor of radiology,
presented "Head and neck
imaging, a case-based review"
at Saint Louis University,
St. Louis, Missouri, April 7.

I

Karen Wooley, PhD, professor of chemistry and of
radiology, spoke on "Polymer
chemistry as applied to the
emerging field of nanotechnology" at the Society of Professors Emeriti, Washington
University, St. Louis, Missouri, January 14. She spoke
on "Synthetic methods for
the preparation of well-defined
nanostructures, designed as
versatile scaffolds for imaging and therapy of acute
vascular injury, cancer, and
other targets" at the Institute
for Environmental Medicine,
University of Pennsylvania
Medical Center, Philadelphia,
February 8. She presented
"Polymer chemistry as
applied to the emerging field
of nanotechnology: with
emphasis on devices for
nanomedicine" at the University of California, Irvine,
March 12, and at Central
Michigan University, Mt.
Pleasant, April 23. Wooley
presented "Shell crosslinked
nanoparticles and hyperbranched fluoropolymers,
each designed as complex
nanostructures for imaging
and therapeutic delivery in
the diagnosis and treatment
of pediatric brain cancers"
at the Pediatrics Weekly
Department Forum, Washington University, St. Louis,
Missouri, March 25. She
spoke on "Amphiphilic,
nanoscopically resolved
crosslinked networks:
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unusual surface anti-fouling
character, sub-surface host
behavior, and bulk modulus
property" at Rice University,
Houston, Texas, March 28.
She spoke on "Shell crosslinked knedel-like (SCK)
nanoparticles and hyperbranched fluoropolymers
(HBFP)" at Johns Hopkins
University, Baltimore, Maryland, April 1. Wooley presented "RAFTpolymerization
of functional monomers" at
the 235"'American Chemical
Society National Meeting,
New Orleans, Louisiana,
April 6. She presented "Synthesis and characterization
of well-defined poly(acrylic
acid)-containing homo- and
block (co)polymers" at The
Mitsubishi Chemical Corporation, Tokyo, Japan, April 21.

SYMPOSIA
In this section ofFYI, only
those faculty and staff who
have Department of Radiology appointments are listed.

SOCIETY OF GASTROINTESTINAL RADIOLOGISTS
AND SOCIETY OF UROLOGY
Abdominal Radiology
Course 2008
Rancho Mirage, California
February 17-22, 2008
Dennis Balfe, MD, "Cases
for aces"; "ABR update";
"Imaging the peritoneal
cavity: pearls and pitfalls."

Jay Heiken, MD, "CT
colonography: MDCT technique"; "Diagnosing benign
liver lesions with CT and
MR"; Imaging the pancreas:
neoplastic and inflammatory
disease."
Christine Menias, MD,
"CT of lower abdominal
pain"; "Acute gynecology
conditions: US and CT."
Cary Siegel, MD, "Solid
renal mass and role for
renal mass biopsy."

CARDIAC CT
ANGIOGRAPHY:
A PRACTICAL APPROACH
Sponsored by American
Roentgen Ray Society
Ft. Lauderdale, Florida
February 29-March 1, 2008
Sanjeev Bhalla, MD,
course director.
Sanjeev Bhalla, MD, "Casebased presentation: cardiac
masses and pericardium."
Cylen Javidan-Nejad, MD,
"Artifacts and coronary artery
disease," "Case-based presentation: artifacts and CAD."
Kevin Johnson, MD,
"Quantification and characterization of coronary plaque."
Marilyn Siegel, MD, "CT
of adult congenital heart
disease," "Case-based presentation: CHD."

SOCIETY OF INTERVENTIONAL RADIOLOGY
33'* Annual Scientific
Meeting
Washington, DC
March 15-20, 2008
Michael Darcy, MD,
"Morbidity and mortality:
learning from our mistakes";
"Cases 10-12: case-based
review: embolization";
"Microcatheter in peripheral."
Colin Derdeyn, MD,
"Endovascular stroke intervention: now and in the future."
Craig Glaiberman, MD;
Benjamin Jacobs; James
Duncan, MD, PhD;
Thomas Pilgram, PhD,
"Simulation in training: one
year experience using a performance to assess IR fellow
training status."
Nael Saad, MD; Craig
Glaiberman, MD, "CTguided percutaneous cryoablation of unresectable renal
tumors: initial outcomes."
Nael Saad, MD; Christine
Menias, MD; Thomas
Pilgram, PhD; Daniel
Picus, MD, "Portal vein
embolization for future liver
remnant hypertrophy prior
to trisegmentectomy: choice
of embolic agent."
Suresh Vedantham, MD,
"Post-thrombolitic syndrome: endovascular";
"Thrombolysis/clot management"; "Case-based review:
DVT and filters."
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SYMPOSIA
Continued from page 31

ASSOCIATION OF UNIVERSITY RADIOLOGISTS
56"' Annual Meeting
Seattle, Washington
March 25-29, 2008
Jennifer Demertzis, MD;
Meghan Lubner, MD; Sara
Rohr, MD, moderators,
"AaCR2 problem solving 1."
Jennifer Demertzis, MD;
Meghan Lubner, MD; Sara
Rohr, MD, moderators,
"A'CR2 problem solving 2:
the role of informatics in
optimizing resident education."
Bennett Greenspan, MD
moderator, "Society of
Nuclear Medicine Session:
Radiation safety radiopharmacy and regulatory issues—
an update for senior radiology
residents."
Christine Peterson, MD,
moderator; Faculty:
Jonathan Baker, MD;
Dennis Balfe, MD; Sanjeev
Bhalla, MD; Jennifer
Demertzis, MD; Travis
Hillen, MD; Meghan
Lubner, MD; Sara Rohr,
MD; Jason Stephenson,
MD, "Philips Vydareny imaging interpretation competition
—preliminary (presented by
Mallinckrodt Institute of
Radiology)."
Joshua Shimony, MD,
PhD, "Informatics and functional brain connectivity."

AMERICAN ROENTGEN
RAY SOCIETY
108'" Annual Meeting
Washington, DC
April 13-18, 2008
Sanjeev Bhalla, MD, "CT
evaluation of pulmonary
embolic disease"; "CT of
acute lung and pleural:
traumatic and nontraumatic
findings"; "Cardiovascular
imaging: CXR findings of
cardiac disease"; "Congenital
conditions."
Jay Heiken, MD, "The
PREDICT study: a randomized
double-blind comparison of
contrast-induced nephropathy after a low- or iso-osmolar
contrast agent in high-risk
patients."
Cylen Javidan-Nejad, MD,
"Cardiovascular imaging:
coronary arteries."
Meghan Lubner, MD;
Sanjeev Bhalla, MD;
Cylen Javidan-Nejad, MD;
Christine Menias, MD,
"Atypical imaging features of
fibrosing mediastinitis."
Meghan Lubner, MD;
Christine Menias, MD;
Christine Peterson, MD;
Sanjeev Bhalla, MD,
"Atypical imaging features of
gastrointestinal (GI) stromal
tumors."
Prakash Masand, MD;
Marilyn Siegel, MD,
"Noninvasive evaluation of
post surgical cardiovascular
conduits in the pediatric age
group using multidetector
imaging."
Prakash Masand, MD;
Sushilkumar Sonavane,
MD; Marilyn Siegel, MD,
"CT angiography of abdominal coarciation in children."

Christine Menias, MD, "CT
of acute intestinal ischemia
and bleeding"; "Wunderlich's
syndrome (nontraumatic
perirenal hemorrhage)
revisited: cross-sectional
imaging spectrum"; "Borderline ovarian tumors: of
borderline significance?"
Marilyn Siegel, MD,
"Imaging of pediatric abdominal emergencies."
Pamela Woodard, MD,
Keynote Lecture—"Cardiac
CT: the future."

SOCIETY FOR PEDIATRIC
RADIOLOGY

51s' Annual Meeting and
Postgraduate Course
Scottsdale, Arizona
May 6-10, 2008

Steven Don, MD; Bruce
Whiting, PhD; Parinaz
Massoumzadeh, PhD,
"Evaluation of quality assurance control phantom
for digital neonatal chest
projection imaging."
—Caffey Award for Best
Basic Science Paper
William McAlister, MD,
"Bisphosphonate-induced
osteopetrosis: novel bone
modeling defects, osteosclerosis fractures, and metaphyseal osteopenia after drug
exposure ceases"; "Physeal
closure from chronic vitamin

A intoxication"; "Osteoprotegerin deficiency (Juvenile
Paget's disease): responses
to oral and IV bisphosphonates in 3 children"; "Molecular exclusion of mutations in
EXT; and EXT2 as the cause
of metachondromatosis."
Prakash Masand, MD;
Marilyn Siegel, MD, "CT
angiography of pulmonary
atresia, pre and post repair";
"Patterns of delayed myocardial enhancement on cardiac
MRI in pediatric patients
with myocarditis."
Prakash Masand, MD;
Rebecca Hulett-Browning,
MD, "Multidetector CT
angiography in the evaluation of congenital thoracic
aortic anomalies in the
pediatric age group."
Marilyn Siegel, MD,
"Cardiac CTA: congenital
heart disease."
Sushilkumar Sonavane,
MD; Madelyn Stazzone,
MD, "Prenatal fetal MRI
imaging in genitourinary
abnormalities."
Madelyn Stazzone, MD,
"Osteomyelitis of the pubic
symphisis: MR findings and
pitfalls in diagnosis"; "2Dflash sequences: Should they
be part of the standard
Oprotocol for fetal MRI?"

Editor's Note: In the listing of MIR's 2007 RSNA Grant
Recipients (page 6 in the Winter 2007/2008 issue of
Focal Spot), the Toshiba Research Scholar Grant
should have read: Jeffrey Lin, MD, PhD, "Noninvasive
characterization of NFkB activation in non-alcoholic
fatty liver disease."
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Imaging Sciences Retreat
C

Pathways to Discovery

Below: David Piwnico-Worms, PhD, professor of radiology and
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Above: As part

EE

Evelhoch, PhD, director ot Imaging Sciences Imaging at Amgen, Inc., discussed
"Imaging in the biopharmoceutical industry."
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director of the Washington University Molecular Imaging Center.

